Cargando…
Exploring the Metabolic Vulnerabilities of Epithelial–Mesenchymal Transition in Breast Cancer
Metastasis and drug resistance are the leading causes of death for breast cancer patients. Epithelial–mesenchymal transition (EMT), a transition from polarized epithelial cells to motile mesenchymal cells mediated by a series of activation signals, confers breast tumor cells with enhanced stem cell,...
Autores principales: | Sun, Xiangyu, Wang, Mozhi, Wang, Mengshen, Yao, Litong, Li, Xinyan, Dong, Haoran, Li, Meng, Li, Xiang, Liu, Xing, Xu, Yingying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393287/ https://www.ncbi.nlm.nih.gov/pubmed/32793598 http://dx.doi.org/10.3389/fcell.2020.00655 |
Ejemplares similares
-
Role of Proton-Coupled Monocarboxylate Transporters in Cancer: From Metabolic Crosstalk to Therapeutic Potential
por: Sun, Xiangyu, et al.
Publicado: (2020) -
Updated Bayesian Network Meta-Analysis of Adjuvant Targeted Treatment Regimens for Early Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer
por: Li, Xinyan, et al.
Publicado: (2020) -
Can ACEI/ARB prevent the cardiotoxicity caused by chemotherapy in early-stage breast cancer?—a meta-analysis of randomized controlled trials
por: Dong, Haoran, et al.
Publicado: (2020) -
Cortactin in Epithelial–Mesenchymal Transition
por: Ji, Rong, et al.
Publicado: (2020) -
Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Sun, Xiangyu, et al.
Publicado: (2020)